Asthma Drug Segment Dominated the Overall Asthma and COPD Market at USD 14,509.1 Million
Everyone wants to breathe the air of freedom without any major hindrance or respiratory problem. However, in many cases, people suffer from breathing problems that can arise from pneumonia, asthma, emphysema, or chronic obstructive pulmonary disease, also commonly known as (COPD).
View full press release